Trial Profile
A Phase 3, Randomized, Double-Blind, Comparative Trial of Two Dosing Regimens of Micafungin (FK463) Versus Caspofungin for the Treatment of Esophageal Candidiasis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Apr 2014
Price :
$35
*
At a glance
- Drugs Micafungin (Primary) ; Caspofungin
- Indications Oral candidiasis
- Focus Registrational; Therapeutic Use
- Sponsors Astellas Pharma
- 08 Apr 2014 Profile updated from Antimicrobial Agents and Chemotherapy.
- 08 Apr 2014 New trial record